Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ramona Bledea"'
Autor:
Neil K Jairath, Redina Bardhi, John S Runge, Ramona Bledea, Ruple Jairath, Yang Wang, Matthew Patrick, Ryan A Wilcox, Alexandra C Hristov, Lam C Tsoi, Trilokraj Tejasvi
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0277655 (2022)
BackgroundLarge cell transformation (LCT) of Sezary Syndrome (SS) is a rare phenomenon. To date, there are no rigorous studies identifying risk factors for its development.ObjectivesHere, we seek to characterize the clinicopathologic risk factors tha
Externí odkaz:
https://doaj.org/article/28b925af818c44d3bc342ef64dce3a01
Autor:
Ramona Bledea, Thomas Scharnitz
Publikováno v:
Michigan Journal of Medicine. 6
Enfortumab vedotin (EV) is a novel drug targeting solid tumors expressing Nectin-4, such as metastatic urothelial carcinoma (mUC). While trials have supported its efficacy, there have also been early reports of cutaneous toxicity that have not yet be
Autor:
Alexandra C. Hristov, Yang Wang, Trilokraj Tejasvi, Matthew Patrick, Lam C. Tsoi, Redina Bardhi, Ruple Jairath, Ramona Bledea, John S. Runge, Ryan A. Wilcox, Neil K. Jairath
ObjectivesLarge cell transformation (LCT) of Sezary Syndrome (SS) is associated with an aggressive clinical course. To date, there are no rigorous studies identifying risk factors for the development of this phenomenon. We aim to characterize the cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10fc8feb8e8517655476ebeb8daa129c
https://doi.org/10.1101/2020.06.01.20119669
https://doi.org/10.1101/2020.06.01.20119669
Autor:
Andreas Kloetgen, Jorge S. Reis-Filho, Gianna Esposito, Seema Patel, Jonathan Serrano, Aristotelis Tsirigos, John G. Golfinos, Nina Goodman, Andrew S. Chi, Britta Weigelt, Dimitris G. Placantonakis, Matija Snuderl, James M. Stafford, A. John Iafrate, Varshini Vasudevaraja, Lilian M. Tredwin, David Zagzag, Ramona Bledea, Snjezana Dogan, Sarah Chiang, Erik P. Sulman
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
IDH1/2 mutations are early drivers present in diverse human cancer types arising in various tissue sites. IDH1/2 mutation is known to induce a global hypermethylator phenotype. However, the effects on DNA methylation across IDH mutant cancers and fun
Autor:
Ramona Bledea, Ahmed Zaher
Publikováno v:
Child's Nervous System. 32:1957-2040
Autor:
Trilokraj Tejasvi, Alexandra C. Hristov, Lam C. Tsoi, Ramona Bledea, Ryan A. Wilcox, Neil K. Jairath, R. Bardhi, John S. Runge, R. Jairath, Matthew Patrick
Publikováno v:
Annals of Oncology. 31:S742
Autor:
Matija Snuderl, Shruti Nayak, Mirna Lechpammer, Jean-Pierre Gagner, Varshini Vasudevaraja, Beatrix Ueberheide, David Zagzag, Scott Kamen, Ramona Bledea, Jonathan Serrano
BACKGROUND: Tumor heterogeneity presents a major challenge to cancer diagnosis and treatment. In addition to interpatient tumor variability, intratumoral heterogeneity characterized by distinct molecular and phenotypic profiles is increasingly recogn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51fcbc20cd6c1caa273f45af2ed7e5f
https://europepmc.org/articles/PMC6216566/
https://europepmc.org/articles/PMC6216566/
Autor:
Crystalann Rodriguez, Gabriel Redel-Traub, Eveline Teresa Hidalgo, Jeffrey H. Wisoff, Cordelia Orillac, Ramona Bledea, Yosef Dastagirzada, Emily North, Michelle W McQuinn, Svetlana Kvint
Publikováno v:
World neurosurgery. 117
Background Duraplasty is a technique successfully used to treat Chiari malformation type I (CM-I). This study describes the timely manner of clinical outcomes and the postoperative course after craniectomy and duraplasty for the treatment of symptoma
Autor:
Joshua Silverman, John G. Golfinos, Stephen Kelly, Andrew S. Chi, Donato Pacione, Ramona Bledea, L.M. Katz, Sylvia Kurz, Benjamin Liechty, Peter Wu, Jonathan Serrano, Varshini Vasudevaraja, Matija Snuderl
Publikováno v:
Neuro-Oncology. 20:vi106-vi106
BACKGROUND: Up to 20% of meningiomas are aggressive tumors with high recurrence rates and poor prognosis. Biomarkers predicting the risk of an unfavorable clinical course are lacking although aberrations in NF2, increased copy number variations and a
Autor:
Nadeem R. Abu-Rustum, Matija Snuderl, Ramona Bledea, Robert A. Soslow, Shengyang Wu, Lien Hoang, Sarah Chiang, Gulisa Turashvili, Jonathan Serrano
Publikováno v:
Journal of Clinical Oncology. 36:e17570-e17570
e17570Background: There is considerable morphologic overlap between FIGO grade (G) 3 endometrioid and serous carcinomas. Serous carcinomas have increased propensity for lymphovascular and peritonea...